BCL10 Antikörper (N-Term) (APC)
Kurzübersicht für BCL10 Antikörper (N-Term) (APC) (ABIN2209255)
Target
Alle BCL10 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 27-55, N-Term
-
Kreuzreaktivität
- Human, Maus
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu Mo
-
Produktmerkmale
- BCL10, NT (BCL10, CIPER, CLAP, B Cell lymphoma/leukemia 10, B Cell CLL/lymphoma 10, CARD-containing molecule enhancing NF-kappa-B, CARD-like apoptotic protein, CED-3/ICH-1 prodomain homologous E10-like regulator, Cellular homolog of vCARMEN, Cellular-E10, Mammalian CARD-containing adapter molecule E10) (APC)
-
Aufreinigung
- Purified by Protein A affinity chromatography.
-
Immunogen
- BCL10 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 27-55 amino acids from the N-terminal region of human BCL10.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- 4°C ,Do Not Freeze
-
-
- BCL10 (B-Cell CLL/lymphoma 10 (BCL10))
-
Andere Bezeichnung
- BCL10
-
NCBI Accession
- NP_003912
-
UniProt
- O95999
-
Pathways
- T-Zell Rezeptor Signalweg, Fc-epsilon Rezeptor Signalübertragung, Activation of Innate immune Response, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Positive Regulation of Endopeptidase Activity, BCR Signaling, Ubiquitin Proteasome Pathway, S100 Proteine
Target
-